Provider Alert! Update to Recertification or Extension Prior Authorization Requests for Nusinersen (Spinraza)
Date: July 23, 2024 Attention: All Providers Effective date: July 1, 2024 Call to action: The purpose of this communication is to inform providers that effective for dates of service on or after July 1, 2024, recertification and extension prior authorization requests for nusinersen (Spinraza) will be subject to medical director review for additional 12-month periods. How this impacts providers: Providers should reference the current Texas Medicaid Provider Procedures Manual, Outpatient Drug Services Handbook, subsection 6.10.1.2 “Recertification/Extension Requests (for all Antisense Oligonucleotides),” for additional recertification...